After AdComm rejection, Mallinckrodt’s stannsoporfin gets stiff-armed at FDAAllbiopro2018-08-23T01:55:28+09:008월 23rd, 2018|
AbbVie licenses GARP checkpoint inhibitor from ArgenxAllbiopro2018-08-23T01:55:00+09:008월 23rd, 2018|
Cel-Sci CEO paints ‘promising future’ in letter to shareholdersAllbiopro2018-08-23T01:54:34+09:008월 23rd, 2018|
Bavarian Nordic: €30m loan to support smallpox vaccine fill/finish plantAllbiopro2018-08-23T01:53:40+09:008월 23rd, 2018|
Oxford Genetics: CRISPR patent war casts shadow over use in cell line developmentAllbiopro2018-08-23T01:53:12+09:008월 23rd, 2018|
Why some people with brain markers of Alzheimer’s have no dementiaAllbiopro2018-08-23T01:51:49+09:008월 23rd, 2018|
New type 1 diabetes therapy shows promise for long-term reversalAllbiopro2018-08-23T01:51:21+09:008월 23rd, 2018|
After seeing POC data, Kyowa advances Parkinson’s program despite being dropped by Lundbeck Allbiopro2018-08-21T02:16:53+09:008월 21st, 2018|
AstraZeneca spinout Entasis files for $86M IPO to fund antibiotic phase 3Allbiopro2018-08-21T02:16:25+09:008월 21st, 2018|
Poised for phase 3, Galera’s GC4419 wards off radiation side effectsAllbiopro2018-08-21T02:15:57+09:008월 21st, 2018|
NICE stands firm on ‘no’ vote for Roche’s Perjeta in postsurgery breast cancerAllbiopro2018-08-21T02:15:30+09:008월 21st, 2018|
Amgen’s quick Aimovig launch boosts blockbuster hopes for Lilly, Teva and Alder: analystAllbiopro2018-08-21T02:15:04+09:008월 21st, 2018|
AstraZeneca, its new HQ delayed and way over budget, weighs a construction partner swap: reportAllbiopro2018-08-21T02:14:37+09:008월 21st, 2018|
Pfizer responds to FDA, EMA and Canada after reinspections of plant that makes injected painkillersAllbiopro2018-08-21T02:14:09+09:008월 21st, 2018|
